Publication | Open Access
LncRNA HANR Promotes Tumorigenesis and Increase of Chemoresistance in Hepatocellular Carcinoma
97
Citations
28
References
2017
Year
Our results demonstrate that HANR contributes to the development of HCC and is a promising therapeutic target for chemosensitization of HCC cells to doxorubicin, which may represent a promising therapeutic target in the future.
| Year | Citations | |
|---|---|---|
Page 1
Page 1